LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer

NCT06778512 · clinicaltrials.gov ↗

RECRUITING

Status

2500

Enrollment

OTHER

Sponsor class

Conditions

Lung
Lung Cancer
Cancer
NSCLC

Interventions

OTHER: Using tissue and peripheral blood proteomics to distinguish the benign and malignant nature of lung cancer in patients, as well as to evaluate therapeutic efficacy and long-term prognosis during the t

Sponsor

The First Affiliated Hospital of Guangzhou Medical University